Permascand has appointed Nariman Askarieh as interim Global Chief Commercial Officer (CCO). Nariman joins from his most recent role as Nordic Commercial Director at the global medical technology company Stryker and will assume his role on March 15, 2023.
Nariman Askarieh Askarieh holds an M. Sc. in Industrial Management and Engineering and has about twenty years of experience in leadership positions in multinational companies such as Stryker, Philips Health Systems, Ericsson, and Tetra Pak.
"With Nariman Askarieh, we have a Chief Commercial Officer with international experience from several different sectors and markets worldwide. His experience and expertise will be important as we take the next step on our continued growth journey, where we meet the increasing demand driven by the global green transition," said CEO Peter Lundström.
"Permascand has had a strong development in recent years where the company's electrochemical solutions are central in many clean-tech applications. I look forward to working with the team to strengthen the company's offering, not least linked to the fast-growing market for green hydrogen where Permascand will achieve the great commercial potential in the area," said Nariman Askarieh, incoming interim CCO for Permascand.
Nariman Askarieh succeeds Viktoria Lindstrand Munkby, who is leaving Permascand for a role at another company.